SG&G Corporation (KOSDAQ:040610)
3,130.00
+10.00 (0.32%)
At close: Jun 10, 2026
SG&G Corporation Revenue
SG&G Corporation had revenue of 12.47B KRW in the quarter ending March 31, 2026, with 8.58% growth. This brings the company's revenue in the last twelve months to 48.68B, down -0.27% year-over-year. In the year 2025, SG&G Corporation had annual revenue of 47.70B, down -6.04%.
Revenue (ttm)
48.68B
Revenue Growth
-0.27%
P/S Ratio
1.08
Revenue / Employee
798.07M
Employees
61
Market Cap
52.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.70B | -3.07B | -6.04% |
| Dec 31, 2024 | 50.76B | 8.86B | 21.16% |
| Dec 31, 2023 | 41.90B | -820.70M | -1.92% |
| Dec 31, 2022 | 42.72B | 6.97B | 19.50% |
| Dec 31, 2021 | 35.75B | -4.64B | -11.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IGLOO | 158.71B |
| Jin Yang Pharmaceutical | 122.15B |
| HCT Co., Ltd. | 106.58B |
| S-Energy | 106.24B |
| Corentec | 102.38B |
| HLB bioStep | 73.96B |
| KL-Net | 47.55B |
| Panstar Enterprise | 28.38B |